Key Takeaways
1. Sjögren’s disease is more serious than many people realize. It is not just dry eyes and dry mouth. Sjögren’s is a systemic autoimmune disease. That means the immune system attacks the body’s own tissues. It can affect the joints, lungs, nerves, and kidneys. There is also an increased risk of lymphoma.
2. Millions of people are living with Sjögren’s — and many don’t know it yet. An estimated 1 to 4 million Americans have Sjögren’s disease. Greater public awareness can help people recognize symptoms and get diagnosed sooner. High-profile voices like Venus Williams and Halsey are helping make that happen.
3. New treatments are in development right now. Researchers are actively studying promising new therapies in clinical trials. These are real, structured scientific programs targeting multiple pathways in the immune system. For people living with Sjögren’s, the science is moving forward. That is reason for real hope.
Sjögren’s disease is in the news this week. (https://nypost.com/2026/02/21/health/the-health-disorder-venus-williams-halsey-and-solange-knowles-have-in-common/)
And that’s a good thing.
When public figures like Venus Williams, Halsey, and Solange Knowles talk about living with Sjögren’s, more people learn the name. More people feel seen. Awareness matters.
But as awareness grows, accuracy matters too.
Sjögren’s disease (often shortened to SjD) is not just dry eyes and dry mouth.
It is a systemic autoimmune disease. That means the immune system attacks the body’s own tissues. It can affect the eyes and mouth, yes. But it can also affect joints, lungs, nerves, kidneys, and other organs. Many patients experience severe fatigue. There is also an increased risk of lymphoma.
This is a serious immune condition.
The good news is that the science is moving.
Researchers are actively studying new treatments in real human clinical trials. These include medicines that target:
- B cells
- The CD40/CD40L pathway
- Interferon signaling
- JAK pathways
- FcRn mechanisms
Multiple companies and academic centers are investing in this work. These are not theoretical ideas. These are structured, regulated clinical programs.
If you want to see the landscape yourself, ClinicalTrials.gov currently lists dozens of active or recruiting studies for Sjögren’s disease: https://clinicaltrials.gov
At CreakyJoints, we talk with people living with autoimmune disease every day. We see the burden. We also see the innovation pipeline and the hope that comes with it.
We believe patients deserve both awareness and scientific clarity.
Sjögren’s is not a niche condition. It affects an estimated 1–4 million people in the United States alone. It deserves serious coverage, serious research, and serious public understanding.
As attention increases, let’s make sure the full story is told.
Because autoimmune disease is complicated.
And the progress is real.
Learn More – Check out the Health Advocates episode:
What Sjögren’s Really Looks Like: Cristina Montoya on Living, Advocating, and Educating
Track Your Symptoms and Disease Activity
Join CreakyJoints’ patient-centered research registry to track your symptoms, disease activity, and medications — and share with your doctor. Learn more and sign up here.
